Cognex Corporation $CGNX Stock: Robeco Institutional Asset Management B.V. Increases Stake

Robeco Institutional Asset Management B.V. boosted its holdings in Cognex Corporation (NASDAQ:CGNX – Free Report) by 25.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 500,783 shares of the scientific and technical instruments company’s stock after buying an additional 100,148 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.30% of Cognex worth $30,372,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Blue Jean Financial LLC acquired a new position in Cognex during the third quarter worth about $3,229,000. Focused Alpha LLC lifted its holdings in shares of Cognex by 41.0% in the third quarter. Focused Alpha LLC now owns 8,452 shares of the scientific and technical instruments company’s stock worth $513,000 after acquiring an additional 2,458 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Cognex by 15.7% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 10,250 shares of the scientific and technical instruments company’s stock valued at $622,000 after purchasing an additional 1,391 shares in the last quarter. IFP Advisors Inc boosted its stake in shares of Cognex by 35.0% in the 3rd quarter. IFP Advisors Inc now owns 1,291 shares of the scientific and technical instruments company’s stock valued at $78,000 after purchasing an additional 335 shares in the last quarter. Finally, TD Waterhouse Canada Inc. boosted its stake in shares of Cognex by 28.9% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 6,696 shares of the scientific and technical instruments company’s stock valued at $417,000 after purchasing an additional 1,503 shares in the last quarter. Institutional investors own 88.12% of the company’s stock.

Cognex Stock Down 5.9%

Shares of CGNX opened at $54.60 on Friday. The stock has a market cap of $9.18 billion, a PE ratio of 53.01 and a beta of 1.48. Cognex Corporation has a 12-month low of $34.60 and a 12-month high of $72.88. The business has a 50-day simple moving average of $60.58 and a two-hundred day simple moving average of $61.86.

Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.03. Cognex had a return on equity of 13.50% and a net margin of 16.05%. The firm had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. During the same period last year, the firm posted $0.25 earnings per share. The business’s revenue for the quarter was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities research analysts expect that Cognex Corporation will post 1.68 EPS for the current year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were paid a $0.0850 dividend. The ex-dividend date of this dividend was Thursday, August 20th. This represents a $0.34 annualized dividend and a dividend yield of 0.6%. Cognex’s dividend payout ratio is currently 33.01%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CGNX shares. Wall Street Zen lowered shares of Cognex from a “buy” rating to a “hold” rating in a report on Sunday, September 13th. Citigroup reissued a “neutral” rating and issued a $74.00 price objective (up from $72.00) on shares of Cognex in a research note on Friday, August 7th. Weiss Ratings upgraded shares of Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Barclays raised their target price on shares of Cognex from $80.00 to $85.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $91.00 target price on shares of Cognex in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $75.57.

Check Out Our Latest Report on Cognex

Cognex Company Profile

(Free Report)

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company’s product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

Further Reading

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.